FutuRx

FutuRx is a biotech incubator founded by three leading global healthcare players – Takeda (Takeda Ventures Inc.), Johnson & Johnson (JJDC), and OrbiMed Israel Partners. By combining the expertise of its management and the capabilities of its founders, FutuRx provides a unique model for the transformation of breakthrough discoveries into novel medicines. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.